GSK (GSK) subsidiary Tesaro confirms it has initiated litigation against AnaptysBio (ANAB) in the Delaware Chancery Court. This action contends ...

Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced that ProFound Therapeutics and Quotient Therapeutics have entered into separate ...

GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GlaxoSmithKline (GSK) has announced the purchase of 243,000 of its own ordinary shares ...

GSK plc (NYSE:GSK) is included among the 12 Best European Dividend Stocks to Buy Now. On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile ...

Agios Pharmaceuticals Inc. reported top-line data from its 52-week Rise Up trial testing oral pyruvate kinase activator mitapivat in sickle cell disease (SCD), which hit statistical significance on ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to ...

GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

OXFORD, England, Nov. 18, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today announced the successful completion of the research phase ...

GSK plc and the Fleming Initiative have announced six major new research programs to find new ways to slow the progress of ...

Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.